[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Chudi Ndubaku<\/i><\/u><\/presenter>. ORIC Pharmaceuticals, South San Francisco, CA","CSlideId":"","ControlKey":"59aa2377-2b08-4ead-9c25-3990245b9d4f","ControlNumber":"76","DisclosureBlock":"&nbsp;<b>&nbsp;C. Ndubaku:<\/b>  ; ORIC Pharmaceuticals. ; ORIC Pharmaceuticals.","End":"4\/9\/2022 10:01:00 AM","HasWebcast":null,"Highlights":[],"Id":"62","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Chudi Ndubaku, PhD","PresenterKey":"5fc7e6db-d155-42e9-b8e2-fb581e1ec204","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"13","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic, Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jeffrey Mckenna<\/i><\/u><\/presenter>. Novartis, Cambridge, MA","CSlideId":"","ControlKey":"a920557b-c505-4d45-86c9-2bf57d1e59be","ControlNumber":"77","DisclosureBlock":"&nbsp;<b>&nbsp;J. Mckenna:<\/b>  ; Novartis Institutes for Biomedical Research. ; Novartis Institutes for Biomedical Research.","End":"4\/9\/2022 10:01:00 AM","HasWebcast":null,"Highlights":[],"Id":"63","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jeffrey Mckenna, PhD","PresenterKey":"bd553796-4842-4d71-af11-0405583b45bf","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"13","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic, Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>George Katibah<\/i><\/u><\/presenter>. RAPT Therapeutics, Inc., South San Francisco, CA","CSlideId":"","ControlKey":"dd8c829a-4b44-480c-9368-daa190b68fb4","ControlNumber":"8551","DisclosureBlock":"<b>&nbsp;G. Katibah, <\/b> <br><b>RAPT Therapeutics<\/b> Employment, Yes.","End":"4\/9\/2022 10:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"16542","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"George Katibah","PresenterKey":"ba4a3b3d-b2fd-4bb1-b1d9-8acffcd2c871","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"HPK1 inhibition: The key to unleashing tumor-specific T cell responses","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"13","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic, Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"HPK1 inhibition: The key to unleashing tumor-specific T cell responses","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"12d9cf00-ec60-49f9-8d4e-973f8231ba70","ControlNumber":"8552","DisclosureBlock":"","End":"4\/9\/2022 10:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"16543","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"13","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic, Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Simone Bonazzi<\/i><\/u><\/presenter>. Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA","CSlideId":"","ControlKey":"92e7f782-191a-4b50-a202-3e1838a6692c","ControlNumber":"8603","DisclosureBlock":"<b>&nbsp;S. Bonazzi, <\/b> <br><b>Novartis<\/b> Employment, Yes.","End":"4\/9\/2022 10:50:00 AM","HasWebcast":null,"Highlights":[],"Id":"17427","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Simone Bonazzi, PhD","PresenterKey":"36eef0a7-999a-436c-ba03-776e889a9d2c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discovery and characterization of NVP-DKY709: A first-in-class selective IKZF2 glue degrader","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"13","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic, Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:30:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discovery and characterization of NVP-DKY709: A first-in-class selective IKZF2 glue degrader","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"8bc9f5b8-dc92-427b-b988-4e49b25e7dde","ControlNumber":"8553","DisclosureBlock":"","End":"4\/9\/2022 11:00:00 AM","HasWebcast":null,"Highlights":[],"Id":"16544","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"13","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic, Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy","ShowChatLink":"false","Start":"4\/9\/2022 10:50:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Chudi Ndubaku<\/i><\/u><\/presenter>. ORIC Pharmaceuticals, South San Francisco, CA","CSlideId":"","ControlKey":"93c7dfff-3ad0-4b34-b09c-573cd1cfa026","ControlNumber":"8556","DisclosureBlock":"","End":"4\/9\/2022 11:20:00 AM","HasWebcast":null,"Highlights":[],"Id":"16547","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Chudi Ndubaku, PhD","PresenterKey":"5fc7e6db-d155-42e9-b8e2-fb581e1ec204","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Optimizations leading to ORIC-533: A potent orally bioavailable CD73 inhibitor that restores anti-tumor immunity in high AMP environments","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"13","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic, Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy","ShowChatLink":"false","Start":"4\/9\/2022 11:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Optimizations leading to ORIC-533: A potent orally bioavailable CD73 inhibitor that restores anti-tumor immunity in high AMP environments","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"3e65376c-c7a9-4aa6-a09a-2e9927ae14d6","ControlNumber":"8554","DisclosureBlock":"","End":"4\/9\/2022 11:30:00 AM","HasWebcast":null,"Highlights":[],"Id":"16545","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  9 2022 10:00AM","SessionId":"13","SessionOnDemand":"False","SessionTitle":"Chemistry to the Clinic, Part 2 of 3: Progress in Small Molecule Cancer Immunology Therapy","ShowChatLink":"false","Start":"4\/9\/2022 11:20:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""}]